Page last updated: 2024-09-03

n,n-dimethylarginine and glucose, (beta-d)-isomer

n,n-dimethylarginine has been researched along with glucose, (beta-d)-isomer in 1 studies

Compound Research Comparison

Studies (n,n-dimethylarginine)	Trials (n,n-dimethylarginine)	Recent Studies (post-2010) (n,n-dimethylarginine)	Studies (glucose, (beta-d)-isomer)	Trials (glucose, (beta-d)-isomer)	Recent Studies (post-2010) (glucose, (beta-d)-isomer)
2,216	228	1,221	21,956	883	10,747

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Bosch, A; Fromm, MF; Gemeinhardt, A; Gessner, A; Kannenkeril, D; Maas, R; Mayr, A; Schmieder, RE; Staerk, C	1

Trials

1 trial(s) available for n,n-dimethylarginine and glucose, (beta-d)-isomer

Article	Year
Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers. Cardiovascular diabetology, 2022, 01-06, Volume: 21, Issue:1 Topics: Arginine; Benzhydryl Compounds; Biomarkers; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome	2022

Article

Year

Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers.

Cardiovascular diabetology, 2022, 01-06, Volume: 21, Issue:1

Topics: Arginine; Benzhydryl Compounds; Biomarkers; Blood Glucose; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Glucosides; Glycated Hemoglobin; Humans; Male; Middle Aged; Predictive Value of Tests; Prospective Studies; Sodium-Glucose Transporter 2 Inhibitors; Time Factors; Treatment Outcome

2022